Document is current
Any future updates will be listed below
-
Authors
Sivakumar, Anirudh https://orcid.org/0000-0003-0788-6476
Phuengkham, Hathaichanok https://orcid.org/0000-0003-4083-2752
Rajesh, Hitha
Mac, Quoc D. https://orcid.org/0000-0003-2745-4734
Rogers, Leonard C. https://orcid.org/0000-0002-2913-4454
Silva Trenkle, Aaron D. https://orcid.org/0000-0001-9331-6191
Bawage, Swapnil Subhash https://orcid.org/0000-0001-9139-5375
Hincapie, Robert https://orcid.org/0000-0001-7358-4543
Li, Zhonghan
Vainikos, Sofia
Lee, Inho https://orcid.org/0009-0008-5668-8621
Xue, Min https://orcid.org/0000-0002-8136-6551
Qiu, Peng https://orcid.org/0000-0003-3256-0734
Finn, M. G. https://orcid.org/0000-0001-8247-3108
Kwong, Gabriel A. https://orcid.org/0000-0002-6255-6755
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (5U01CA265711, 5R01CA237210, 1DP2HD091793, 5DP1CA280832, T32GM145735, 5U01CA265711, 5U01CA265711)
National Science Foundation (DGE-2039655, DGE-2039655)
- License Information
-
More Information
Article History
Received: 16 April 2024
Accepted: 30 October 2024
First Online: 3 January 2025
Competing interests
: G.A.K. is an equity shareholder of, and consults for, Sunbird Bio and Port Therapeutics. This study could affect his personal financial status. The terms of this arrangement have been reviewed and approved by Georgia Tech in accordance with its conflict-of-interest policies. A.S., Q.D.M. and G.A.K. are listed as inventors on patent application (PCT/US2020/030132) pertaining to the results of the paper. The patent applicant is the Georgia Tech Research Corporation. The patent is published (WO2020191416A3). The remaining authors declare no competing interests.
